logo, Hepcinat-LP capsules suppliers ,Hepcinat-LP capsules manufacturers ,Hepcinat-LP capsules ,Hepcinat-LP capsules exporters India


Hepatitis C is a viral infection that causes inflammation of the liver. Genotypes are used to identify particular strains of HCV which are based upon differences in particular regions of the viral genome. Hepcinat Ip (Gilead Sciences, Inc.) is a prescription care which contains a combination of Hepcinat and Ledipasvir in the dosages form of 90mg and 400 mg that is used for treatment of Chronic Hepatitis C (CHC) genotype 1 infection in adults. It is not recognized yet if Hepcinat Ip is safe and effective care for children under 18 years of age.

Genotype 1 HCV is the most common infection accounting for 70 to 75% of the entirely Hepatitis C infections in the UNITED STATES. Ledipasvir and Hepcinat are antiviral medications that help to prevent hepatitis C virus (HCV) cells from multiplying in your body.

The Indian generic of Hepcinat Ip to be manufactured by NATCO PHARMA LIMITED will soon be available in INDIA under the trade name HEPCINAT-LP. This drug will also have similar effects as Hepcinat Ip in treating Chronic Hepatitis C (CHC) genotype 1 infection in adults. The recommended dosage of Hepcinat-LP is one tablet taken orally once daily with or without food.


  • Trade Name :- HEPCINAT-LP
  • Drug Form :- care will be available in the form of Tablets
  • Generic Name :- The generic name is Ledipasvir
  • International Trade Name :- Hepcinat Ip (Gilead Sciences, Inc.)
  • .

  • Manufactured by :- NATCO PHARMA LTD
  • Active Ingredients :- Ledipasvir 90mg and Hepcinat 400mg
  • Packing :- Pack of 28 Tablets
  • Place Your Order

    Please share your contact details and we will get in touch with you soon.

    Resolve the simple captcha below:
    3 + 15 =

    NOTE : Hepcinat-LP is a prescription drug and should be used under proper medical guidance and advice.